Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary

letter

. 1996 Mar 16;312(7032):702–705.

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.

PMCID: PMC2350527 PMID: 8597746

These references are in PubMed. This may not be the complete list of references from this article.

Fleming T. R., Harrington D. P., O'Brien P. C. Designs for group sequential tests. Control Clin Trials. 1984 Dec;5(4):348–361. doi: 10.1016/s0197-2456(84)80014-8. [DOI] [PubMed] [Google Scholar]
Lees A. J. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. BMJ. 1995 Dec 16;311(7020):1602–1607. doi: 10.1136/bmj.311.7020.1602. [DOI] [PMC free article] [PubMed] [Google Scholar]
Olanow C. W., Hauser R. A., Gauger L., Malapira T., Koller W., Hubble J., Bushenbark K., Lilienfeld D., Esterlitz J. The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol. 1995 Nov;38(5):771–777. doi: 10.1002/ana.410380512. [DOI] [PubMed] [Google Scholar]
Przuntek H., Welzel D., Blümner E., Danielczyk W., Letzel H., Kaiser H. J., Kraus P. H., Riederer P., Schwarzmann D., Wolf H. Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued. Eur J Clin Pharmacol. 1992;43(4):357–363. doi: 10.1007/BF02220609. [DOI] [PubMed] [Google Scholar]